Sign In
Buy ACB
$3.42
-0.0900 (-2.56%)
At Close: Jun 03, 2026
Aurora Cannabis Advises of Second False Article from Investing.com
07:39am, Thursday, 19'th Jun 2025
NASDAQ | TSX: ACB EDMONTON, AB , June 19, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has bec
Aurora Cannabis Denies News of Acquisition of MedLeaf Therapeutics
04:34pm, Wednesday, 18'th Jun 2025
NASDAQ | TSX: ACB EDMONTON, AB , June 18, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has be
Aurora Cannabis: Poland Headwinds Result In Disappointing Outlook (Rating Downgrade)
03:20pm, Wednesday, 18'th Jun 2025
Aurora Cannabis reported mixed Q4/FY2025 results, with higher-than-expected revenues offset by lower profitability due to a number of one-time expenses. Following substantial growth in recent quarters
Aurora Cannabis Inc. (ACB) Q4 2025 Earnings Call Transcript
10:43am, Wednesday, 18'th Jun 2025
Aurora Cannabis Inc. (NASDAQ:ACB ) Q4 2025 Earnings Conference Call June 18, 2025 8:00 AM ET Company Participants Kevin Niland - Corporate Participant Miguel Martin - CEO & Executive Chairman Simona K
Aurora Cannabis Stock Falls as Canadian Producer Expects International Sales to Decline
10:31am, Wednesday, 18'th Jun 2025
Aurora Cannabis (ACB) shares tumbled Wednesday as the Canadian cannabis operator said it expects “temporary declines” in its international markets, which include the U.S.
Canadian Medical Marijuana Firm Aurora Cannabis Expects Weak Demand In International Market
10:30am, Wednesday, 18'th Jun 2025
Canada-based medical marijuana company Aurora Cannabis Inc.'s ACB stock is trading lower after it released its fourth quarter 2025 earnings.
Aurora Cannabis Shares Fall on Polish Setback, Higher Costs in 4Q
10:30am, Wednesday, 18'th Jun 2025
Aurora Cannabis slid Wednesday morning after the company said regulatory headwinds in Poland hit prescription volumes and higher logistics costs pressured margins in the fiscal fourth quarter.
Aurora Cannabis Inc. (ACB) Misses Q4 Earnings Estimates
09:41am, Wednesday, 18'th Jun 2025
Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.11 per share a year ago.
Aurora Cannabis, Bitdeer Technologies Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
08:35am, Wednesday, 18'th Jun 2025
U.S. stock futures were higher this morning, with the Dow futures gaining more than 50 points on Wednesday.
Aurora Cannabis 4Q Loss Narrows as Medical Cannabis Drives Revenue Beat
07:25am, Wednesday, 18'th Jun 2025
Aurora Cannabis's loss narrowed in its fiscal fourth quarter thanks to strong growth in its medical-cannabis business.
Aurora Cannabis Files Full Year Results and Announces Fiscal 2025 Fourth Quarter
07:00am, Wednesday, 18'th Jun 2025
NASDAQ | TSX: ACB Achieves Record Annual Global Medical Cannabis Net Revenue 1 of $244.4 million, representing 39% YoY growth Delivers Record Adjusted EBITDA 1 of $49.7 million, representing 261% Yo
Aurora Cannabis: Poised For Its First Profitable Year
09:46am, Monday, 16'th Jun 2025
Aurora Cannabis is on track for its first profitable year, driven by a strategic pivot to high-margin medical cannabis and disciplined cost management. Strong international medical sales, improved mar
Aurora Expands Medical Cannabis Offerings in Australia with the Launch of IndiMed TEMPO 22
07:00am, Thursday, 05'th Jun 2025
NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company Adds Two New Cultivars to Popular Brand Portfolio in the Australian Market EDMONTON, AB , June 5, 2025 /PRNewswire/ - Aurora Cannabis Inc
Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2025 Investor Conference Call and File Related Year End Information
04:15pm, Tuesday, 03'rd Jun 2025
NASDAQ | TSX: ACB EDMONTON, AB , June 3, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, anno
June 2025 Watchlist: Best Canadian Cannabis Stocks for Growth
10:00am, Saturday, 31'st May 2025
As of June 2025, the U.S. cannabis industry continues its rapid expansion. Projections estimate the market will reach approximately $45 billion in revenue this year. This growth is fueled by increasin
